Our latest investment in our mission at Qkine to produce the highest quality growth factors for research. The most state-of-the-art automated system which fills, labels and caps vials with minimal manual intervention.
Qkine wins 'Scale-up of the Year' at the 2024 Cambridge Independent Business Awards On the 26th September 2024, Qkine representatives Catherine Elton, CEO and Luana Ferrara, Head of R&D and Collaborations joined some of the most impressive Cambridge business leaders for an exciting evening of networking and entertainment at the [...]
In this edition, we are excited to announce our complete transition to animal origin-free (AOF) manufacturing for all recombinant proteins. This ensures the highest quality and consistency for researchers relying on these critical components. Additionally, discover our latest application notes featuring AOF BDNF and GDNF for neural differentiation and thermostable FGF-2 and TGF-β1 for weekend-free iPSC culture.
This recent publication in collaboration with Qkine focusses on the optimization of home-brew media for the maintenance of human induced pluripotent stem cells (hiPSCs), using Qkine growth factors to allow cost-effective, practical, and reproducible culture of hiPSCs. Qkine thermostable tag-free FGF2-G3 proteins were found to be highly bioactive, necessitating an 8-fold reduction in concentration for the short (145 aa) form of FGF2-G3 in the optimized media.
Qkine is pleased to announce a new global sales distribution agreement with AI driven digital research platform Scientist.com on their Product Hub Marketplace.
Hematopoietic stem cells (HSCs) are at the forefront of a transformative shift in modern medicine, beginning to revolutionize patient care by offering novel therapeutic treatments for a wide range of diseases. This review blog summarizes advances in the clinical use of HSCs in HSC transplantation.
Qkine expands senior leadership with the appointment of Rob Nixon, Commercial Director, and Paul Grafham, Chief Financial Officer Qkine is delighted to announce the appointment of Rob Nixon to its leadership team as Commercial Director and Paul Grafham as Chief Financial Officer. With years of experience working with fast-growing biotechs and life science [...]
Qkine is pleased to announce that it has successfully been recertified with the international standard ISO 9001:2015 by the globally respected UKAS accredited BSI, giving enhanced confidence in the assessment of best practices. This standard shows our dedication to raising the standard of bioactive proteins through implementation of continual improvement, scientific innovation and exceptional scientific and customer support
In this edition, we are excited to discuss our conversations at ISSCR 2024 about the stem cell science supply chain and impact of growth factors and cytokines quality on reproducibility, including how to integrate new technologies, such as controlled-release and thermostable proteins. We are also pleased to announce our collaboration with the superb team at StemCultures, launch high quality food grade PDGF-BB, publish a new application note focusing on dopaminergic neuron differentiation and welcome to our team Paul Grafham, CFO and Rob Nixon, Commercial Director.
Qkine is a company run by scientists, and the science is the focus of everything we do.Our theme at ISSCR this year was stress-free stem cell culture - exploring how suppliers of recombinant proteins can proactively improve the quality, availability and functionality of growth factors to generate experimental outcomes faster, easier and more efficiently.We discussed priorities for the stem cell science supply chain with scientists from academic and industry labs and had in-depth conversations about the impact of growth factors and cytokines quality on reproducibility and how to integrate new technologies, such as controlled-release and thermostable proteins, to improve the scalability of expansion and differentiation protocols.Through collaboration, we learn and, together, improve the future of stem cell research.
© 2024 Qkine Ltd. Company number 10470662 registered in England and Wales. All rights reserved
